2. Search Result
Search Result
Results for "

reference

" in MedChemExpress (MCE) Product Catalog:

265

Inhibitors & Agonists

5

Screening Libraries

25

Fluorescent Dyes

24

Biochemical Assay Reagents

7

Peptides

3

MCE Kits

191

Inhibitory Antibodies

15

Natural
Products

1

Click Chemistry

3

Oligonucleotides

Targets Recommended:
Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-P99355
    Bimagrumab
    3 Publications Verification

    Anti-ACVR2B reference Antibody; BYM338

    		 TGF-β Receptor Metabolic Disease
    Bimagrumab (Anti-ACVR2B Reference Antibody) is a human monoclonal antibody that blocks activin type II receptor (ActRII), with KDs of 1.7 pM and 434 pM for human ActRIIB and ActRIIA, respectively. Bimagrumab can be used for the research of pathological muscle loss and weakness .
    Bimagrumab
  • HY-B0594
    Iohexol
    5 Publications Verification

    		 Autophagy Mitophagy Cancer
    Iohexol is a non-ionic, water-soluble contrast agent used as a reference marker for the determination of glomerular filtration rate (GFR) at the level of renal function. Iohexol can be used for contrast in myelography, computerized tomography (cisternography, ventriculography) and MicroCT imaging .
    Iohexol
  • HY-P99372
    Lorvotuzumab

    Anti-NCAM1/ CD56 reference Antibody (lorvotuzumab)

    		 ADC Antibody Cancer
    Lorvotuzumab (Anti-NCAM1/CD56 Reference Antibody (lorvotuzumab)) is a humanized monoclonal antibody that binds CD56 (NCAM1). Lorvotuzumab can be used to synthesize an ADC compound, Lorvotuzumab mertansine .
    Lorvotuzumab
  • HY-P99361
    Enavatuzumab

    PDL192; ABT-361; Anti-TNFRSF12A/TWEAKR/CD266 reference Antibody (enavatuzumab)

    		 TNF Receptor Cancer
    Enavatuzumab (PDL192; ABT-361) is a humanized IgG1 monoclonal antibody targeting the receptor of TNF-like weak inducer of apoptosis (TWEAK). TWEAK (Fn14; TNFRSF12A), the natural ligand of the TWEAK receptor (TweakR), stimulates multiple cellular responses. Enavatuzumab induces tumor growth inhibition through direct TweakR signaling and antibody dependent cell-mediated cytotoxicity (ADCC). Enavatuzumab can actively recruits and activates myeloid effectors to kill tumor cells. Enavatuzumab inhibits the growth of various human TweakR-positive cancer cell lines and xenografts in vitro and in vivo .
    Enavatuzumab
  • HY-150150
    SiRNA Negative Control
    20+ Cited Publications

    		 Small Interfering RNA (siRNA) Inflammation/Immunology
    SiRNA Negative Control is a siRNA of 21 nucleotides, and can be used as a negative control. SiRNA Negative Control has no homology to most known gene sequence. SiRNA Negative Control can be used in human, mouse and rat cells in vitro. SiRNA Negative Control can be used as experimental control benchmark, verification of experimental reliability and standardization reference. SiRNA Negative Control is a common negative control used in most research articles.
    SiRNA Negative Control
  • HY-W116335A
    Dried aluminum hydroxide gel,United States Pharmacopeia (USP) Reference Standard

    		Environmental Pollutants Biochemical Assay Reagents Inflammation/Immunology
    Dried aluminum hydroxide gel, United States Pharmacopeia (USP) Reference Standard is a commonly used antacid with remarkable compound adhesion and release activity. Dried aluminum hydroxide gel, United States Pharmacopeia (USP) Reference Standard can effectively neutralize gastric acid and relieve stomach discomfort. Dried aluminum hydroxide gel, United States Pharmacopeia (USP) Reference Standard is also often used as an adjuvant in vaccines to enhance immune responses. Dried aluminum hydroxide gel, United States Pharmacopeia (USP) Reference Standard can improve the stability and bioavailability of compounds in preparations .
    Dried aluminum hydroxide gel,United States Pharmacopeia (USP) Reference Standard
  • HY-P99364
    Icrucumab
    1 Publications Verification

    Anti-VEGFR1/FLT1 reference Antibody; IMC-18F1

    		 VEGFR Apoptosis p38 MAPK Akt Endocrinology Cancer
    Icrucumab (Anti-VEGFR1/FLT1 Reference Antibody; IMC-18F1) is an IgG1 antibody inhibitor targeting VEGFR-1/FLT1 with anti-tumor activity. By blocking ligand-dependent phosphorylation and downstream signal transduction, Icrucumab reduces the activities of MAPK and Akt in breast cancer xenograft models, inhibits the proliferation and invasion of VEGFR-1-positive tumor cells, and reverses the conversion of M1 macrophages to the pro-tumor M2-like phenotype. Icrucumab also inhibits tumor cell proliferation, promotes apoptosis, and effectively suppresses tumor growth through direct targeting of tumors and host support mechanisms. In addition, Icrucumab exhibits a synergistic effect when combined with chemotherapeutic agents, and it is used in research related to various cancers including advanced solid malignancies, thyroid cancer, melanoma, and lung cancer .
    Icrucumab
  • HY-P99351
    Andecaliximab

    Anti-MMP9 reference Antibody (andecaliximab)

    		 MMP Cancer
    Andecaliximab is a recombinant chimeric IgG4 monoclonal antibody (mAb) targets matrix metalloproteinase 9 (MMP9). Andecaliximab shows the antifibrotic efficacy in idiopathic pulmonary fibrosis mouse models. Andecaliximab can be used for the research of gastric adenocarcinoma and idiopathic pulmonary fibrosis (IPF) .
    Andecaliximab
  • HY-P99376
    Narsoplimab
    1 Publications Verification

    OMS 721; Anti-MASP2 reference Antibody (narsoplimab)

    		 SARS-CoV Infection
    Narsoplimab (OMS 721) is a high-affinity fully human immunoglobulin gamma 4 (IgG4) monoclonal antibody that binds MASP-2 and blocks lectin pathway activation. Narsoplimab can be used in research of hematopoietic stem-cell transplantation and SARS-CoV-2 .
    Narsoplimab
  • HY-P99379
    Nidanilimab (Nadunolimab)

    CAN04; Anti-IL-1RAP/IL-1R3 reference Antibody (nidanilimab)

    		 Interleukin Related Cancer
    Nidanilimab (CAN04) is a fully humanized monoclonal anti-IL1RAP antibody with a Kd value of 1.10 pM. Nidanilimab blocks IL1α and IL1β signaling and stimulates the immune system to destroy tumour cells. Nidanilimab can be used in research of non-small lung cancer (NSCLC) and pancreatic ductal adenocarcinoma (PDAC) .
    Nidanilimab (Nadunolimab)
  • HY-P99357
    Crotedumab

    REGN1193; Anti-GCGR reference Antibody (crotedumab)

    		 GCGR Metabolic Disease
    Crotedumab (REGN1193) is a fully human IgG4 monoclonal antibody that binds and inhibits glucagon receptor (GCGR), with a KD of 0.1 nM. Crotedumab can be used for the research of diabetes .
    Crotedumab
  • HY-P99356
    Cinpanemab

    BIIB054; Anti-Alpha-synuclein reference Antibody (cinpanemab)

    		 α-synuclein Neurological Disease
    Cinpanemab (BIIB054) is a human-derived monoclonal antibody that binds to α-synuclein. Cinpanemab can be used for the research of Parkinson's disease .
    Cinpanemab
  • HY-P99370
    Landogrozumab
    1 Publications Verification

    LY2495655; Anti-GDF8 / Myostatin reference Antibody (landogrozumab)

    		 TGF-beta/Smad Inflammation/Immunology Cancer
    Landogrozumab (LY2495655) is an humanized anti-myostatin monoclonal antibody. Landogrozumab effectively improves muscle volume, hand grip strength and function. Landogrozumab can be used for the research of muscle wasting disease .
    Landogrozumab
  • HY-148436
    Glucocorticoid receptor agonist-2 Ala-Ala-Mal

    		Drug-Linker Conjugates for ADC Inflammation/Immunology
    Glucocorticoid receptor agonist-2 Ala-Ala-Mal (compound 79) can be used to synthesize anti-inflammatory ADC molecules. Glucocorticoid receptor agonist-2 is an active reference for ABBV-3373 .
    Glucocorticoid receptor agonist-2 Ala-Ala-Mal
  • HY-P99374
    Naratuximab
    1 Publications Verification

    Anti-TSPAN26/CD37 reference Antibody (naratuximab)

    		 ADC Antibody Cancer
    Naratuximab (Anti-TSPAN26/CD37 Reference Antibody (naratuximab)) is a humanized monoclonal antibody that binds CD37 (TSPAN26). Naratuximab can be used to synthesize an ADC compound, Naratuximab emtansine .
    Naratuximab
  • HY-P99363
    Feladilimab

    Anti-ICOS/CD278 reference Antibody (feladilimab); GSK3359609

    		 Transmembrane Glycoprotein Cancer
    Feladilimab (Anti-ICOS/CD278 Reference Antibody (feladilimab); GSK3359609) is humanized IgG4 anti-ICOS/CD278 agonist monoclonal antibody. Feladilimab can be used for the research of cancer .
    Feladilimab
  • HY-148676
    Emilumenib

    DS-1594a; Menin-MLL inhibitor 26

    		 Epigenetic Reader Domain Cancer
    Emilumenib (Menin-MLL inhibitor 26) is an orally active Menin-MLL inhibitor. Emilumenib also is an active reference. Emilumenib can inhibits cell growth. Emilumenib can be used for the research of leukemia .
    Emilumenib
  • HY-P99377
    Navicixizumab

    OMP-305B83; Anti-DLL4 reference Antibody (navicixizumab)

    		 Notch Cancer
    Navicixizumab (OMP-305B83) is a bispecific anti-VEGF and anti-DLL4 inhibitory antibody. Navicixizumab can combine with Paclitaxel (HY-B0015) for cancer research. Navicixizumab can be used in the research of ovarian, primary peritoneal, or fallopian tube cancer .
    Navicixizumab
  • HY-P990358
    Anti-CD7 Antibody

    		Transmembrane Glycoprotein Inflammation/Immunology
    Anti-CD7 Antibody is a recombinant monoclonal antibody targeting CD7, and it is mainly used as a reference antibody.
    Anti-CD7 Antibody
  • HY-P99359
    Elezanumab

    ABT-555; AE12-1Y-QL; Anti-RGMA reference Antibody (elezanumab)

    		 TGF-beta/Smad Metabolic Disease
    Elezanumab (ABT-555; AE12-1Y-QL) is a human monoclonal antibody that selectively targets repulsive guidance molecule A (RGMa). Elezanumab potently inhibited RGMa mediated BMP signalling via the SMAD1/5/8 pathway, with an IC50 around 97 pM. Elezanumab promotes neuroregeneration and neuroprotection in neuronal injury and demyelination models binds N-terminal RGMa, blocks BMP signaling and lacks RGMc cross-reactivity. elezanumab has neuroregenerative and neuroprotective activities without impact on iron metabolism .
    Elezanumab
  • HY-P99378
    Neihulizumab

    ALTB-168; Anti-PSGL1/CD162 reference Antibody (neihulizumab); AbGn-168

    		 Apoptosis Inflammation/Immunology
    Neihulizumab (ALTB-168) is an immune checkpoint agonistic antibody that binds to human CD162 (PSGL-1), leading to downregulation of activated T-cells. Neihulizumab can be uesd for steroid-refractory acute graft-versus-host-disease (SR-aGVHD), psoriasis, psoriatic arthritis and ulcerative colitis research .
    Neihulizumab
  • HY-P99358
    Dezamizumab

    GSK 2398852; Anti-Serum Amyloid P/SAP reference Antibody (dezamizumab)

    		 Complement System Inflammation/Immunology
    Dezamizumab (GSK 2398852) is a fully humanized clonal IgG1 antibody against serum amyloid P component (SAP) with complement activation and amyloid clearance-inducing activities. Dezamizumab binds to SAP associated with amyloid deposits to form complexes that activate complement and mediate phagocytic clearance, triggering activation of the classical complement pathway. Dezamizumab can be used for the research of systemic amyloidosis .
    Dezamizumab
  • HY-P99375
    Narnatumab

    IMC-RON8; LY3012219; Anti-MSPR/RON/CD136 reference Antibody (narnatumab)

    		 Tyrosinase c-Met/HGFR Cancer
    Narnatumab (IMC-RON8) is a neutralizing human monoclonal antibody that blocks RON binding to its ligand, macrophage-stimulating protein (MSP), with a Kd of 32 pM. Narnatumab can be used for the research of cancer .
    Narnatumab
  • HY-102048
    STAT5-IN-2
    2 Publications Verification

    		 STAT Apoptosis Cancer
    STAT5-IN-2 is a STAT5 inhibitor, extracted from reference 1, example 17f. STAT5-IN-2 has potent antileukemic effect .
    STAT5-IN-2
  • HY-D0043
    5(6)-ROX
    1 Publications Verification

    5(6)-Carboxy-X-rhodamine

    		 DNA Stain Others
    5(6)-ROX (5(6)-Carboxy-X-rhodamine) is a nucleic acid fluorescent label which can be used as a reference dye for real-time polymerase chain reaction (Em/Ex = 605/585 nm) .
    5(6)-ROX
  • HY-148435
    Glucocorticoid receptor agonist-2

    		Glucocorticoid Receptor ADC Payload Inflammation/Immunology
    Glucocorticoid receptor agonist-2 (compound 21) is an glucocorticoid receptor agonist with an IC50 value of 6.6 nM. Glucocorticoid receptor agonist-2 can be used to synthesize anti-inflammatory ADC molecules. Glucocorticoid receptor agonist-2 is an active reference of ABBV-3373 .
    Glucocorticoid receptor agonist-2
  • HY-W098756
    Thionordiazepam

    Demethylsulazepam

    		 Biochemical Assay Reagents Neurological Disease
    Thionordiazepam is a benzodiazepine compound and serves as an analytical reference standard for benzodiazepine-related psychoactive substances .
    Thionordiazepam
  • HY-P99353
    Ascrinvacumab
    2 Publications Verification

    Anti-ACVRL1 / ALK-1 reference Antibody (ascrinvacumab); PF-03446962; GT-90001C

    		 Anaplastic lymphoma kinase (ALK) Cancer
    Ascrinvacumab (PF-03446962) is a human IgG2 monoclonal antibody targets ALK-1. Ascrinvacumab shows binding efficiency with human ALK1 with a Kd value of 7 nM. Ascrinvacumab can be used for the research of hepatocellular carcinoma (HCC) .
    Ascrinvacumab
  • HY-13231
    CDK9-IN-1
    1 Publications Verification

    		 CDK HIV Infection
    CDK9-IN-1 is a novel, selective CDK9 inhibitor for the treatment of HIV infection, with an IC50 of 39 nM for CDK9/CycT1, extracted from reference, compound 87.
    CDK9-IN-1
  • HY-P99360
    Enapotamab

    Anti-AXL/UFO reference Antibody (enapotamab)

    		 TAM Receptor ADC Antibody Cancer
    Enapotamab (Anti-AXL/UFO Reference Antibody) is an AXL/UFO-related antibody that can be used for synthesis of ADC molecule Enapotamab vedotin (HY-P99921) .
    Enapotamab
  • HY-P991104
    Anti-EMMPRIN/CD147 Antibody

    		Integrin Metabolic Disease
    Anti-EMMPRIN/CD147 Antibody is a human antibody expressed in CHO cells, targeting Basigin. Anti-EMMPRIN/CD147 Antibody can be referenced as Human IgG1 kappa, Isotype Control (HY-P99001).
    Anti-EMMPRIN/CD147 Antibody
  • HY-P990501
    Anti-RSPO1 Antibody

    		Wnt β-catenin Inflammation/Immunology
    Anti-RSPO1 Antibody is a humanized antibody expressed in CHO that targets RSPO1. The isotype control for Anti-RSPO1 Antibody can be referenced as Mouse IgG2a kappa, Isotype Control (HY-P99978).
    Anti-RSPO1 Antibody
  • HY-N7861
    Methyl elaidate

    Methyl trans-9-Octadecenoate; (E)-Methyl octadec-9-enoate

    		 Biochemical Assay Reagents Others
    Methyl elaidate is a compound belonging to the class of fatty acid esters. It is derived from elaidic acid, a monounsaturated omega-9 fatty acid found in certain vegetable oils and animal fats. Methyl elaidate is commonly used as a reference compound for the analysis of fatty acids and their derivatives by gas chromatography.
    Methyl elaidate
  • HY-W030562
    Bemethyl

    		Others Inflammation/Immunology
    Bemethyl is a synthetic adaptogen that exhibits actoprotector and antihypoxant activities. Bemethyl has the ability to increase the body's resistance to stress and improve physical endurance. Bemethyl regulatory mechanisms include vasodilation and lowering blood sugar and lactate levels. Bemethyl is an analytical reference standard for adaptogen .
    Bemethyl
  • HY-W088875
    Deschlorodiazepam

    		Biochemical Assay Reagents Others
    Deschlorodiazepam is an analytical reference standard categorized as a benzodiazepine .
    Deschlorodiazepam
  • HY-Y0344H
    Sodium chloride, United States Pharmacopeia (USP) Reference Standard

    Halite (Pharmaceutical primary standard, USP)

    		 Biochemical Assay Reagents Na+/K+ ATPase Interleukin Related Inflammation/Immunology Cancer
    Sodium chloride, United States Pharmacopeia (USP) Reference Standard is an orally active salt. Sodium chloride, United States Pharmacopeia (USP) Reference Standard induces the expression of ATP1A1. Sodium chloride, for cell culture induces the pro-inflammatory cytokines IL-2, TNFα, IL-9 and several chemokines. Sodium chloride, United States Pharmacopeia (USP) Reference Standard enhances the anti-tumor activities of Digoxin (HY-B1049) against small cell lung cancer. Sodium chloride, United States Pharmacopeia (USP) Reference Standard drives autoimmune disease by the induction of pathogenic Th17 cells .
    Sodium chloride, United States Pharmacopeia (USP) Reference Standard
  • HY-P99362
    Ensituximab

    Anti-MUC5AC reference Antibody (ensituximab); NEO-102

    		 Mucin Cancer
    Ensituximab (NEO-102; NPC-1C) is a chimeric monoclonal IgG1 antibody targeting a variant of MUC5AC. Ensituximab shows specificity to colorectal and pancreatic cancer .
    Ensituximab
  • HY-Z2337
    Rabeprazole sulfone

    		Drug Intermediate Others
    Rabeprazole sulfone is a metabolite of the proton pump inhibitor Rabeprazole and is an impurity reference for Rabeprazole .
    Rabeprazole sulfone
  • HY-W008813
    1-(3-Methoxyphenyl)piperazine

    		Biochemical Assay Reagents Others
    1-(3-Methoxyphenyl)piperazine (Compound 4) is an analytical reference standard categorized as a piperazine .
    1-(3-Methoxyphenyl)piperazine
  • HY-160849
    N-Desmethyl Rilmazolam

    		GABA Receptor Others Metabolic Disease
    N-desmethyl Rilmazolam, a triazolobenzodiazepine, serves as an analytical reference standard. N-desmethyl Rilmazolam is an active metabolite derived from rilmazafone (HY-106547). N-desmethyl Rilmazolam is designed for use in research and forensic settings .
    N-Desmethyl Rilmazolam
  • HY-P991103
    Anti-IL-25 Antibody

    		Interleukin Related Inflammation/Immunology
    Anti-IL-25 Antibody is a human antibody expressed in CHO cells, targeting IL-25. Anti-IL-25 Antibody can be referenced as Human IgG1 kappa, Isotype Control (HY-P99001).
    Anti-IL-25 Antibody
  • HY-P991109
    Anti-EFNA4 Antibody

    PF-06647263 antibody

    		 Transmembrane Glycoprotein Neurological Disease
    Anti-EFNA4 Antibody (PF-06647263 antibody) is a human antibody expressed in CHO cells, targeting EFNA4. Anti-EFNA4 Antibody can be referenced as Human IgG1 kappa, Isotype Control (HY-P99001).
    Anti-EFNA4 Antibody
  • HY-P991099
    Anti-GLP1R Antibody

    		GCGR Metabolic Disease
    Anti-GLP1R Antibody is a human antibody expressed in CHO cells, targeting GLP1R. Anti-GLP1R Antibody can be referenced as Human IgG1 kappa, Isotype Control (HY-P99001).
    Anti-GLP1R Antibody
  • HY-W015495R
    L-Dihydroorotic acid (Standard)

    		Reference Standards Endogenous Metabolite Dihydroorotate Dehydrogenase Others
    L-Dihydroorotic acid (Standard) is an analytical reference standard for L-Dihydroorotic acid. This product is used for research and analytical applications. L-Dihydroorotic acid is an important intermediate in the metabolism of orotic acid and a substrate of dihydroorotate dehydrogenase (DHODH). L-Dihydroorotic acid can reversibly hydrolyze to yield the acyclic L-ureidosuccinic acid by dihydrowhey enzyme .
    L-Dihydroorotic acid (Standard)
  • HY-W775174
    Citrus red 2

    C.I. Solvent red 80

    		 Fluorescent Dye
    Citrus red 2 (CI Solvent red 80) is a synthetic dye with coloring power and antioxidant activity. Citrus red 2 can be used in food and cosmetics to provide a bright color to the product. Citrus red 2 is also used as a reference substance for testing and analysis in certain situations.
    Citrus red 2
  • HY-P10355
    Succinimide-AFK-AMC acetate

    		Bacterial Infection
    Succinimide-AFK-AMC acetate is a marker for P. aeruginosa protease activity using cultured reference strains .
    Succinimide-AFK-AMC acetate
  • HY-P3363
    Z-DEVD-AMC

    		Caspase Cancer
    Z-DEVD-AMC is a selective caspase-3 substrate that can be measured by fluorescence spectrometry. AMC can be used as a fluorescence reference standard for AMC-based enzyme substrates including AMC-based caspase substrates .
    Z-DEVD-AMC
  • HY-W725213
    α-ethyl 2C-D hydrochloride

    BL-3912; alpha-EH DOM

    		 Biochemical Assay Reagents Others
    α-ethyl 2C-D (BL-3912) hydrochloride is a phenethylamine and amphetamine compound. In drug discrimination studies, α-ethyl 2C-D hydrochloride can serve as a reference standard for MDMA .
    α-ethyl 2C-D hydrochloride
  • HY-13622A
    Elomotecan

    BN 80927 free base

    		 Topoisomerase Cancer
    Elomotecan (BN 80927 free base) is a potent inhibitor of topoisomerases I and II. Elomotecan is a camptothecin analog belonging to the homocamptothecin family (hCPT). Elomotecan reduces the proliferation of different tumor cells with higher potency than other anticancer agents of reference targeting topoisomerases I and II .
    Elomotecan
  • HY-13622
    Elomotecan hydrochloride

    BN 80927

    		 Topoisomerase Cancer
    Elomotecan hydrochloride (BN 80927) is a potent inhibitor of topoisomerases I and II. Elomotecan hydrochloride (BN 80927) is a camptothecin analog belonging to the homocamptothecin family (hCPT). Elomotecan hydrochloride (BN 80927) reduces the proliferation of different tumor cells with higher potency than other anticancer agents of reference targeting topoisomerases I and II .
    Elomotecan hydrochloride

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

  

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

  

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: